PTC
ALXN

Private Trust Company’s Alexion Pharmaceuticals ALXN Stock Holding History

Private Trust Company’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,996
Closed -$2.57M – 408
2021
Q2 		$2.57M Sell
13,996
-1,919
-12% -$329K 0.39% 71
2021
Q1 		$2.43M Sell
15,915
-1,567
-9% -$242K 0.4% 70
2020
Q4 		$2.73M Sell
17,482
-489
-3% -$62.8K 0.46% 57
2020
Q3 		$2.06M Buy
17,971
+3,939
+28% +$425K 0.4% 67
2020
Q2 		$1.57M Sell
14,032
-175
-1% -$18.6K 0.33% 81
2020
Q1 		$1.27M Sell
14,207
-362
-2% -$35.5K 0.33% 83
2019
Q4 		$1.57M Sell
14,569
-4,181
-22% -$447K 0.29% 93
2019
Q3 		$1.84M Buy
18,750
+2,696
+17% +$304K 0.36% 76
2019
Q2 		$2.1M Buy
16,054
+560
+4% +$72.2K 0.42% 62
2019
Q1 		$2.09M Buy
15,494
+2,824
+22% +$351K 0.44% 64
2018
Q4 		$1.23M Buy
12,670
+1,884
+17% +$223K 0.29% 87
2018
Q3 		$1.5M Buy
10,786
+146
+1% +$18.3K 0.31% 80
2018
Q2 		$1.32M Buy
10,640
+2,377
+29% +$278K 0.29% 88
2018
Q1 		$920K Buy
8,263
+354
+4% +$42.3K 0.2% 131
2017
Q4 		$945K Sell
7,909
-9
-0.1% -$1.1K 0.2% 126
2017
Q3 		$1.11M Buy
7,918
+56
+0.7% +$7.61K 0.24% 97
2017
Q2 		$956K Buy
+7,862
New +$915K 0.21% 119
2014
Q4 		– Sell
-71
Closed -$12K – 1325
2014
Q3 		$12K Hold
71
– – ﹤0.01% 1042
2014
Q2 		$11K Sell
71
-48
-40% -$7.58K ﹤0.01% 1065
2014
Q1 		$18K Sell
119
-29
-20% -$4.61K 0.01% 773
2013
Q4 		$20K Hold
148
– – 0.01% 711
2013
Q3 		$17K Buy
148
+7
+5% +$768 0.01% 724
2013
Q2 		$13K Buy
+141
New +$13.6K 0.01% 775

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Private Trust Company's ALXN Position: Q3 2021 in Review

Private Trust Company sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 13,996 shares — an estimated $2.57M sold.

Private Trust Company first reported a position in ALXN in Q2 2013 and held it in 23 quarters. The position peaked at $2.73M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Private Trust Company reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Private Trust Company sold 13,996 Alexion Pharmaceuticals shares in Q3 2021, an estimated $2.57M.
  • Private Trust Company first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 23 quarters.
  • Private Trust Company's Alexion Pharmaceuticals position peaked at $2.73M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Private Trust Company's 13F filing for Q3 2021, filed 6 Oct 2021.